Royer Biomedical Inc

EMINENT Services Corporation, founded in 1997, is a reliable partner for the pharmaceutical and biotechnology industry, providing comprehensive Investigational Drug Management and InfoTech services. With a commitment to quality and compliance, EMINENT supports clinical trials and product commercialization by offering specialized regulatory guidance and cGMP manufacturing of clinical trial materials. Operating from a 57,000 square foot facility in Frederick, MD, EMINENT is equipped with advanced systems for temperature and humidity monitoring, disaster recovery, and online report access. The company holds various licenses and permits, ensuring adherence to stringent regulatory standards while serving research organizations and emerging biopharmaceutical companies. Generated from the website

Incorporated in 1989, Otsuka America Pharmaceutical is a health care company that commercializes its products throughout North America. It offers products under the ABILIFY Tablets1 and PLETAL Tablets2 brands. The company works in collaboration with Bristol-Myers Squibb, which co-develops and co-promotes ABILIFY. Otsuka America Pharmaceutical has also merged with Meretek Diagnostics to form the Meretek Diagnostics Group under the Medical Device Division of OAPI. It focuses on neuroscience, cardiovascular, oncologic and gastrointestinal therapeutic treatments. The company operates Otsuka Maryland Research Institute, which was established as a wholly-owned subsidiary of OAPI to research and develop a variety of health care products. Otsuka America Pharmaceutical is a part of Otsuka Pharmaceutical Group.

As a world leader in auto-injector technology, Meridian Medical Technologies, a King Pharmaceutical company, offers a broad range of auto-injector drug delivery systems and drug formulations for emergency medical use. Each auto-injector is a pre-filled, self-contained, pressure-activated device designed for the quick administration of a precise dose of medication. Unlike a syringe, which can be cumbersome and time-consuming, Meridian s auto-injectors provide a compact, quick and portable delivery system. The design s simplicity, concealed needle and speed of injection render these auto-injectors ideal for self or caregiver. Since the 1960s, the company has partnered with and served as a critical supplier for the United States Department of Defense. Meridian is the only supplier of FDA-approved auto-injectors containing nerve agent antidotes and has produced in excess of 185 million auto-injectors for the world market.